Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...
Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...
Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...
A new review finds that randomised trials increasingly favour individualised, imaging-guided calcium modification over ...
Dublin, March 04, 2020 (GLOBE NEWSWIRE) -- The "Atherectomy Devices Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global atherectomy ...
According to Abbott, the Diamondback 360 system—which it acquired in 2023 through its $890 million purchase of the devicemaker Cardiovascular Systems—has been used to treat over 100,000 patients.
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardio Flow, Inc., a privately held commercial-stage medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results